Jens A.
- Country
- Germany
- Department
- N/A
Research Overview
- I8F-MC-GPHJ: A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Compared to Semaglutide 2.4 mg in Adults Who Have Obesity or Overweight with Weight-Related Comorbidities
- J3L-MC-EZEB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults with Elevated Lipoprotein(a)
- Phase III Study of RO7795068 for Weight Management in Adults With Obesity or Overweight Without Type 2 Diabetes
Data & Insights
Has run more than one trial at 281 of 834 partner sites.
Specializations
Diabetes Management
The investigator specializes in advancing treatment approaches for Type 2 Diabetes Mellitus, with particular focus on evaluating innovative therapeutic agents and their comparative effectiveness.
- GLP-1 Receptor Agonist Therapies
- Treatment Optimization Strategies
- Glycemic Control Assessment
Their research encompasses medication switching protocols and dose optimization in diabetes care.
Diabetic Complications
The investigator focuses on the relationship between diabetes treatment and diabetic retinopathy, studying long-term effects of glucose-lowering medications on eye health.
- Ophthalmic Assessment Methods
- Early Worsening Phenomenon
- Retinopathy Progression Monitoring
Their work includes standardized evaluation of diabetes-related eye complications.
Cardiovascular Outcomes
The investigator studies cardiovascular safety and outcomes in diabetes treatment, particularly examining major adverse cardiovascular events in high-risk patients.
- Cardiovascular Risk Assessment
- Composite Endpoint Analysis
- Long-term Safety Monitoring
Their research evaluates cardiovascular outcomes in relation to diabetes therapeutics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.